Iron Therapy in Patients with Heart Failure and Iron Deficiency: Review of Iron Preparations for Practitioners

被引:0
作者
Marcin Drozd
Ewa A. Jankowska
Waldemar Banasiak
Piotr Ponikowski
机构
[1] Wroclaw Medical University,Laboratory for Applied Research on Cardiovascular System, Department of Heart Diseases
[2] Military Hospital,Cardiology Department, Centre for Heart Diseases
[3] Wroclaw Medical University,Department of Heart Diseases
来源
American Journal of Cardiovascular Drugs | 2017年 / 17卷
关键词
Iron Deficiency; Heart Failure Patient; Iron Therapy; Iron Sucrose; Heart Failure With Reduce Ejection Fraction;
D O I
暂无
中图分类号
学科分类号
摘要
In patients with heart failure (HF), iron deficiency (ID) correlates with decreased exercise capacity and poor health-related quality of life, and predicts worse outcomes. Both absolute (depleted iron stores) and functional (where iron is unavailable for dedicated tissues) ID can be easily evaluated in patients with HF using standard laboratory tests (assessment of serum ferritin and transferrin saturation). Intravenous iron therapy in iron-deficient patients with HF and reduced ejection fraction has been shown to alleviate HF symptoms and improve exercise capacity and quality of life. In this paper, we provide information on how to diagnose ID in HF. Further we discuss pros and cons of different iron preparations and discuss the results of major trials implementing iron supplementation in HF patients, in order to provide practical guidance for clinicians on how to manage ID in patients with HF.
引用
收藏
页码:183 / 201
页数:18
相关论文
共 307 条
[31]  
Attia MA(2011)Regulation of cellular iron metabolism Biochem J 434 365-54
[32]  
Essa SA(2007)Ferritin and ferritin isoforms I: structure–function relationships, synthesis, degradation and secretion Arch Physiol Biochem 113 30-S8
[33]  
Nosair NA(2006)Assessing iron status: beyond serum ferritin and transferrin saturation Clin J Am Soc Nephrol. 1 S4-1091
[34]  
Hughes CM(2009)Rationale and design of Ferinject Assessment in patients with IRon deficiency and chronic Heart Failure (FAIR-HF) study: a randomized, placebo-controlled study of intravenous iron supplementation in patients with and without anaemia Eur J Heart Fail 11 1084-875
[35]  
Woodside JV(2008)Serum transferrin receptor Am J Hematol 83 872-606
[36]  
McGartland C(2011)Iron deficiency in community-dwelling US adults with self-reported heart failure in the National Health and Nutrition Examination Survey III: prevalence and associations with anemia and inflammation Circ Hear Fail. 4 599-1172
[37]  
Lourenço BH(2013)Iron deficiency is a key determinant of health-related quality of life in patients with chronic heart failure regardless of anaemia status Eur J Heart Fail 15 1164-4657
[38]  
Vieira LP(2013)Functional iron deficiency and diastolic function in heart failure with preserved ejection fraction Int J Cardiol 168 4652-326
[39]  
Macedo A(2014)Iron deficiency status irrespective of anemia: a predictor of unfavorable outcome in chronic heart failure patients Cardiology 128 320-1132
[40]  
Hallberg L(2014)Iron deficiency in a multi-ethnic Asian population with and without heart failure: prevalence, clinical correlates, functional significance and prognosis Eur J Heart Fail 16 1125-148